Department of Cardiovascular Medicine, Shaoxing Second hospital, Shaoxing, Zhejiang, China.
Shanghai Biotecan Pharmaceuticals Co., Ltd, Shanghai, China.
BMC Microbiol. 2023 Sep 9;23(1):254. doi: 10.1186/s12866-023-02967-x.
The coexistence of hypertension and type 2 diabetes mellitus (T2DM) may largely increase the risk for cardiovascular disease. However, there is no clear consensus on the association between hypertension and the risk of diabetes. Gut microbiota plays important roles in the development of hypertension and T2DM, but whether there is difference between hypertension patients with or without T2DM has not been explored yet.
We recruited 101 hypertension patients in this study (72 patients without T2DM named HT group and 29 patients with T2DM named HT-T2DM group). Their blood samples were collected for testing clinical characteristics and fecal samples were tested for bacterial DNA using 16 S ribosomal RNA gene sequencing targeting the V3 and V4 region. The data of 40 samples were downloaded from project PRJNA815750 as health control (HC group) in this study. The community composition and structure of the microbiome, taxonomic difference, co-occurrence network and functional enrichment were analyzed by alpha/beta diversity, LEfSe, Fruchterman Reingold's algorithm and PICRUSt2 functional analysis, respectively.
Alpha and beta diversity analysis showed significant differences in microbial community richness and composition among the three groups. The HC group had a significantly higher Simpson index and a distinct microbiota community compared to the HT and HT-T2DM groups, as demonstrated by significant differences in unweighted and weighted UniFrac distances. The LEfSe analysis identified specific taxa that had significantly different abundance among the groups, such as Bacteroides uniformis, Blautia wexlerae, Alistipes putredinis, and Prevotella stercorea in the HC group, Prevotella copri and Phascolarctobacterium faecium in the HT group, and Klebsiella pneumoniae in the HT-T2DM group. Co-occurrence network analysis indicates that Prevotella copri, Mediterraneibacter gnavus, Alistipes onderdonkii and some unidentified species act as key nodes in the network. Differentially functional pathway identified by PICRUSt2 were concentrated in nutrition and energy metabolism, as well as the biosynthesis of other secondary metabolites.
Our study found significant differences in microbial community richness, composition, and function among the healthy controls, hypertension patients with and without T2DM. Some specific taxa may explain this difference and serve as potential therapeutic targets for hypertension, T2DM, and their coexistence.
高血压和 2 型糖尿病(T2DM)的共存可能会大大增加心血管疾病的风险。然而,高血压与糖尿病风险之间的关联尚无明确共识。肠道微生物群在高血压和 T2DM 的发展中起着重要作用,但尚未探讨高血压患者中是否存在 T2DM 的差异。
本研究纳入了 101 例高血压患者(72 例无 T2DM 的高血压患者命名为 HT 组,29 例有 T2DM 的高血压患者命名为 HT-T2DM 组)。采集他们的血液样本进行临床特征检测,采集粪便样本进行 16S 核糖体 RNA 基因测序,靶向 V3 和 V4 区域。本研究还从项目 PRJNA815750 下载了 40 个样本作为健康对照(HC 组)的数据。通过 alpha/beta 多样性、LefSe、Fruchterman Reingold 算法和 PICRUSt2 功能分析分别对微生物组的群落组成和结构、分类差异、共生网络和功能富集进行分析。
alpha 和 beta 多样性分析表明,三组间微生物群落丰富度和组成存在显著差异。HC 组的 Simpson 指数明显较高,微生物群落明显不同于 HT 和 HT-T2DM 组,表现在未加权和加权 UniFrac 距离上有显著差异。LefSe 分析确定了各组之间丰度有显著差异的特定分类群,例如 HC 组中的均匀杆菌、韦克斯勒氏拟杆菌、腐败希瓦氏菌和粪拟杆菌,HT 组中的普雷沃氏菌和粪肠球菌,以及 HT-T2DM 组中的肺炎克雷伯菌。共生网络分析表明,普雷沃氏菌、中间型地中海杆菌、奥尔德登氏拟杆菌和一些未鉴定的物种是网络中的关键节点。通过 PICRUSt2 鉴定的差异功能途径主要集中在营养和能量代谢以及其他次生代谢物的生物合成上。
我们的研究发现,健康对照组、高血压伴或不伴 T2DM 患者的微生物群落丰富度、组成和功能存在显著差异。一些特定的分类群可能解释了这种差异,并可能成为高血压、T2DM 及其共存的潜在治疗靶点。